Search our site 
 
Advanced Search
 
Home | Exam dates | Contact us | About us | Testimonials |
 
 

map
You are in Home >> Resources >> Clinical anaesthesia >> Malignant Hyperthermia

Management of known malignant hyperthermia cases

Created: 27/4/2004

 

Pre-treatment with oral dantrolene 5 mg/kg over 24 hours preoperatively, or 1 mg/kg IV before induction has been used, but is rarely considered now. Management is essentially avoidance of known triggers (N2O is safe). Total IV anaesthesia has been suggested as a useful technique. Some advocate the use of a new anaesthetic machine, others consider a new breathing circuit with flushing of the machine with fresh gas for 20 minutes prior to use.
 

Reference

[i] Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant.
Shime J, Gare D, Andrews J, Britt B.
Am J Obstet Gynecol 1988; 159(4): 831-4.
 
Related examination questions

Final SAQ:
A General Practitioner has contacted you for advice about a patient who may be susceptible to malignant hyperthermia. Write a letter to the General Practitioner, explaining the significance of this condition for the patient and the relatives.
 


ArticleDate:20040427
SiteSection: Article
 
   
    
                                            
  Posting rules

     To view or add comments you must be a registered user and login  




Login Status  

You are not currently logged in.
UK/Ireland Registration
Overseas Registration

  Forgot your password?








 
All rights reserved © 2017. Designed by AnaesthesiaUK.

{Site map} {Site disclaimer} {Privacy Policy} {Terms and conditions}

 Like us on Facebook 

vp